CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-26 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes 10b5-1 | −286 | $171.75 | $49K | 39,559 |
| 2025-02-26 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −229 | $171.75 | $39K | 17,853 |
| 2025-02-26 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −233 | $171.75 | $40K | 11,546 |
| 2025-02-26 | Doherty Catherine T. EVP, Regional Businesses | Shares withheld for taxes 10b5-1 | −455 | $171.75 | $78K | 70,002 |
| 2025-02-26 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −88 | $171.75 | $15K | 35,212 |
| 2025-02-26 | DELANEY MARK E SVP & Chief Commercial Officer | Shares withheld for taxes | −214 | $171.75 | $37K | 5,983 |
| 2025-02-20 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale 10b5-1 | −604 | $170.99 | $103K | 39,845 |
| 2025-02-20 | Doherty Catherine T. EVP, Regional Businesses | Sale 10b5-1 | −899 | $170.99 | $154K | 70,457 |
| 2025-02-19 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −1,031 | $169.71 | $175K | 21,046 |
| 2025-02-19 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes 10b5-1 | −374 | $169.71 | $63K | 40,449 |
| 2025-02-19 | Plewman Patrick SVP for Diagnostic Services | Sale | −320 | $169.71 | $54K | 18,082 |
| 2025-02-19 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −287 | $169.71 | $49K | 11,779 |
| 2025-02-19 | Doherty Catherine T. EVP, Regional Businesses | Sale 10b5-1 | −535 | $169.71 | $91K | 71,356 |
| 2025-02-19 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −99 | $169.71 | $17K | 35,300 |
| 2025-02-19 | DELANEY MARK E SVP & Chief Commercial Officer | Shares withheld for taxes | −242 | $169.71 | $41K | 6,197 |
| 2025-02-19 | Davis J. E. CEO and President | Shares withheld for taxes | −2,936 | $169.71 | $498K | 141,181 |
| 2025-02-12 | Davis J. E. CEO and President | Grant or award | +18,149 | 144,117 | ||
| 2025-02-12 | Davis J. E. CEO and President | Grant or award · Non-Qualifed Stock Option (right to buy) | +69,633 | 69,633 | ||
| 2025-02-12 | SAMAD SAM Executive Vice President & CFO | Grant or award | +4,538 | 22,077 | ||
| 2025-02-12 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +17,403 | 17,403 |
Page 15 of 21 · 409 trades